Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOD1 | Q9Y239 | 11/20 | 0.75 |
| ▸ | SLC6A5 | Q9Y345 | 2/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.56 |
| ▸ | PLA2G2C | Q5R387 | 1/20 | 0.54 |
| ▸ | FAAH | O00519 | 2/20 | 0.51 |
| ▸ | MEN1 | O00255 | 1/20 | 0.51 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.51 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8620771 | 1.00 | NOD1 (0.75) | NOD1SLC6A5KMT2APLA2G2CFAAH | |
| SCHEMBL5496148 | 1.00 | NOD1 (0.75) | NOD1SLC6A5KMT2APLA2G2CFAAH | |
| SCHEMBL28321635 | 0.98 | NOD1 (0.73) | NOD1SLC6A5KMT2APLA2G2CFAAH | |
| Selenium SCHEMBL4401992 | 0.98 | NOD1 (0.73) | NOD1SLC6A5KMT2APLA2G2CFAAH | |
| Alanine SCHEMBL28447182 | 0.92 | NOD1 (0.64) | NOD1SLC6A5KMT2AFAAHMEN1 | |
| SCHEMBL16465238 | 0.92 | SLC6A5 (0.70) | NOD1SLC6A5FAAH | |
| SCHEMBL16465619 | 0.91 | NOD1 (0.63) | NOD1SLC6A5KMT2APLA2G2C | |
| SCHEMBL29010135 | 0.90 | NOD1 (0.73) | NOD1SLC6A5KMT2APLA2G2CFAAH | |
| SCHEMBL10338746 | 0.89 | NOD1 (0.60) | NOD1SLC6A5KMT2APLA2G2CFAAH | |
| SCHEMBL7208303 | 0.88 | KMT2A (0.64) | NOD1KMT2APLA2G2CFAAHMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1655281-B1 | Salts of N-acyl-L-aspartate-beta-mono-ester and/or of N-acyl-L-glutamate-gamma-monoester, the process for preparing them and their use in therapeutic or cosmetic compositions | ASEPTA LAB (MC) | 2009-12-23 | — | — | EP | disclosed |
| WO-2006048430-A1 | SALTS OF N-ACYL-L-ASPARTATE-β-MONOESTER AND/OR OF N-ACYL-L-GLUTAMATE-Ϝ-MONOESTER, METHOD FOR THE PREPARATION THEREOF AND THEIR USE IN THERAPEUTIC OR COSMETIC COMPOSITIONS | LABORATOIRES ASEPTA (MC) | 2006-05-11 | — | — | WO | disclosed |
| EP-1655281-A1 | Salts of N-acyl-L-aspartate-beta-mono-ester and/or of N-acyl-L-glutamate-gamma-monoester, the process for preparing them and their use in therapeutic or cosmetic compositions | Laboratoires Asepta (MC) | 2006-05-10 | — | — | EP | disclosed |